New Clinical and Commercial Opportunities in Digital Health

A Special Issue of Journal of Commercial Biotechnology

Authors

  • Andrew McCulloch Shu Chien Chancellor’s Endowed Chair in Engineering and Medicine, University of California San Diego
  • Kevin Patrick Professor, School of Medicine & School of Public Health, University of California, San Diego
  • Arthur A Boni Editor in Chief, Journal of Commercial Biotechnology

DOI:

https://doi.org/10.5912/jcb1022

Abstract

This special issue of the Journal of Commercial Biotechnology highlights new research and commercial opportunities in the emerging field of digital health. Most of the papers included herein were contributed by authors who presented their work at a one-day webinar on Digital Health held on October 27th, 2021. The Symposium on New Clinical and Commercial Opportunities in Digital Health was hosted by the UC San Diego Institute of Engineering in Medicine (IEM), the Center for Health Innovation at UC San Diego Health (CHI), and the Journal of Commercial Biotechnology (JCB). This issue also includes a few additional papers relevant to the symposium, but not presented there. These have been solicited by the Editor in Chief of JCB to emphasize the importance of employing cross industry best practices for commercialization, and the importance of pricing. 

Downloads

Published

2022-04-29

Issue

Vol. 27 No. 1 (2022): Volume 27, Issue 1 2022

Section

Commentary